Hepatitis C Virus Core Protein Enhances NF-κB Signal Pathway Triggering by Lymphotoxin-β Receptor Ligand and Tumor Necrosis Factor Alpha

ABSTRACT Our previous study indicated that the core protein of hepatitis C virus (HCV) can associate with tumor necrosis factor receptor (TNFR)-related lymphotoxin-β receptor (LT-βR) and that this protein-protein interaction plays a modulatory effect on the cytolytic activity of recombinant form LT-βR ligand (LT-α1β2) but not tumor necrosis factor alpha (TNF-α) in certain cell types. Since both TNF-α/TNFR and LT-α1β2/LT-βR are also engaged in transcriptional activator NF-κB activation or c-Jun N-terminal kinase (JNK) activation, the biological effects of the HCV core protein on these regards were elucidated in this study. As demonstrated by the electrophoretic mobility shift assay, the expression of HCV core protein prolonged or enhanced the TNF-α or LT-α1β2-induced NF-κB DNA-binding activity in HuH-7 and HeLa cells. The presence of HCV core protein in HeLa or HuH-7 cells with or without cytokine treatment also enhanced the NF-κB-dependent reporter plasmid activity, and this effect was more strongly seen with HuH-7 cells than with HeLa cells. Western blot analysis suggested that this modulation of the NF-κB activity by the HCV core protein was in part due to elevated or prolonged nuclear retention of p50 or p65 species of NF-κB in core protein-producing cells with or without cytokine treatment. Furthermore, the HCV core protein enhanced or prolonged the IκB-β degradation triggering by TNF-α or LT-α1β2 both in HeLa and HuH-7 cells. In contrast to that of IκB-β, the increased degradation of IκB-α occurred only in LT-α1β2-treated core-producing HeLa cells and not in TNF-α-treated cells. Therefore, the HCV core protein plays a modulatory effect on NF-κB activation triggering by both cytokines, though the mechanism of NF-κB activation, in particular the regulation of IκB degradation, is rather cell line and cytokine specific. Studies also suggested that the HCV core protein had no effect on TNF-α-stimulated JNK activity in both HeLa and HuH-7 cells. These findings, together with our previous study, strongly suggest that among three signaling pathways triggered by the TNF-α-related cytokines, the HCV core protein potentiates NF-κB activation in most cell types, which in turn may contribute to the chronically activated, persistent state of HCV-infected cells.

[1]  L. Gooding.  Virus proteins that counteract host immune defenses , 1992, Cell.

[2]  C. Rice,et al.  Hepatitis C virus-specific T lymphocyte responses. , 1995, Current opinion in immunology.

[3]  H. Erdjument-Bromage,et al.  IκB-β regulates the persistent response in a biphasic activation of NF-κB , 1995, Cell.

[4]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[5]  C. Ware,et al.  A lymphotoxin-beta-specific receptor. , 1994, Science.

[6]  H. Nakano,et al.  Differential regulation of IκB kinase α and β by two upstream kinases, NF-κB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1 , 1998 .

[7]  R. Heller,et al.  Tumor necrosis factor receptor-mediated signaling pathways , 1994, The Journal of cell biology.

[8]  E. Kieff,et al.  Lymphotoxin-β receptor signaling complex: Role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor κB , 1997 .

[9]  D. Goeddel,et al.  Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Scott F. Smith,et al.  Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. , 1994, Science.

[11]  S. Chen,et al.  Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation , 1995, Journal of virology.

[12]  Michael E. Greenberg,et al.  Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.

[13]  M. Karin,et al.  Selective activation of the JNK signaling cascadeand c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs , 1995, Cell.

[14]  P. Crespo,et al.  The small GTP-binding proteins Rac1 and Cdc42regulate the activity of the JNK/SAPK signaling pathway , 1995, Cell.

[15]  M. Lai,et al.  Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor , 1997, Journal of virology.

[16]  M. Onji,et al.  Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[17]  F. Mackay,et al.  Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice , 1997, European journal of immunology.

[18]  J. Berzofsky,et al.  Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules , 1995, Journal of virology.

[19]  Marty W. Mayo,et al.  TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.

[20]  M. Karin.  The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases (*) , 1995, The Journal of Biological Chemistry.

[21]  M. Lai,et al.  Hepatitis C Virus Core Protein Binds to the Cytoplasmic Domain of Tumor Necrosis Factor (TNF) Receptor 1 and Enhances TNF-Induced Apoptosis , 1998, Journal of Virology.

[22]  A. McDowall,et al.  The human T-cell leukemia virus type 1 transactivator protein Tax colocalizes in unique nuclear structures with NF-kappaB proteins , 1997, Journal of virology.

[23]  L. Williams,et al.  Tumor necrosis factor α‐induced activation of c‐jun N‐terminal kinase is mediated by TRAF2 , 1997, The EMBO journal.

[24]  J. Woodgett,et al.  Cross‐linking CD40 on B cells preferentially induces stress‐activated protein kinases rather than mitogen‐activated protein kinases. , 1996, The EMBO journal.

[25]  K. Meyer,et al.  Suppression of apoptotic cell death by hepatitis C virus core protein. , 1996, Virology.

[26]  C. Ware,et al.  Dominant Negative Mutants of TRAF3 Reveal an Important Role for the Coiled Coil Domains in Cell Death Signaling by the Lymphotoxin-β Receptor* , 1997, The Journal of Biological Chemistry.

[27]  F. Su,et al.  Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins , 1996, Journal of virology.

[28]  M. Yoshida,et al.  A trans-activator Tax of human T-cell leukemia virus type 1 binds to NF-kappa B p50 and serum response factor (SRF) and associates with enhancer DNAs of the NF-kappa B site and CArG box. , 1993, Oncogene.

[29]  B. Beutler,et al.  Unraveling function in the TNF ligand and receptor families. , 1994, Science.

[30]  K. Meyer,et al.  Transcriptional Repression of p53 Promoter by Hepatitis C Virus Core Protein* , 1997, The Journal of Biological Chemistry.

[31]  J. Woodgett,et al.  The stress-activated protein kinase subfamily of c-Jun kinases , 1994, Nature.

[32]  N. Shastri.  Antigen processing and recognition Edited by James McCluskey. Boca Raton: CRC Press. (1991). 257 pp. $139.95 , 1992, Cell.

[33]  M. Yoshida,et al.  Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor kappa B and induces nuclear translocation of transcription factor NF-kappa B proteins for transcriptional activation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Hiscott,et al.  Constitutive phosphorylation and turnover of I kappa B alpha in human T-cell leukemia virus type I-infected and Tax-expressing T cells , 1995, Journal of virology.

[35]  D. Goeddel,et al.  TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40 , 1995, Science.

[36]  D. Goeddel,et al.  Identification and Characterization of an IκB Kinase , 1997, Cell.

[37]  G. Migliaccio,et al.  Biosynthesis and biochemical properties of the hepatitis C virus core protein , 1994, Journal of virology.

[38]  J. Inoue,et al.  MEK Kinase Is Involved in Tumor Necrosis Factor α-Induced NF-κB Activation and Degradation of IκB-α* , 1996, The Journal of Biological Chemistry.

[39]  Michael Karin,et al.  Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death , 1996, Cell.

[40]  E M Schwarz,et al.  Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. , 1995, Genes & development.

[41]  W C Greene,et al.  NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. , 1993, Science.

[42]  Inder M. Verma,et al.  R~~/NF-KB /IKB familv: intimate tales of association and dissociation , 1995 .

[43]  T. Maniatis.  Catalysis by a Multiprotein IκB Kinase Complex , 1997, Science.

[44]  A. Israël,et al.  Promoter analysis of the gene encoding the I kappa B‐alpha/MAD3 inhibitor of NF‐kappa B: positive regulation by members of the rel/NF‐kappa B family. , 1993, The EMBO journal.

[45]  C. Ware,et al.  TRAF5, an Activator of NF-κB and Putative Signal Transducer for the Lymphotoxin-β Receptor* , 1996, The Journal of Biological Chemistry.

[46]  M. Yoshida,et al.  Tax protein of HTLV-1 destabilizes the complexes of NF-kappa B and I kappa B-alpha and induces nuclear translocation of NF-kappa B for transcriptional activation. , 1995, Oncogene.

[47]  P. Marynen,et al.  Construction and evaluation of a hncDNA library of human 12p transcribed sequences derived from a somatic cell hybrid. , 1993, Genomics.

[48]  Ko Okumura,et al.  Tumor Necrosis Factor Receptor-associated Factor (TRAF) 5 and TRAF2 Are Involved in CD30-mediated NFκB Activation* , 1997, The Journal of Biological Chemistry.

[49]  S. Nagata,et al.  Apoptosis by Death Factor , 1997, Cell.

[50]  Jiahuai Han,et al.  Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms , 1995, Science.

[51]  T. McKinsey,et al.  Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB , 1996, Molecular and cellular biology.

[52]  David Baltimore,et al.  An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.

[53]  Human T-cell leukemia virus type I Tax associates with and is negatively regulated by the NF-kappa B2 p100 gene product: implications for viral latency , 1994 .

[54]  C. Ware,et al.  The ligands and receptors of the lymphotoxin system. , 1995, Current topics in microbiology and immunology.

[55]  M. Kohara,et al.  Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[56]  C. Ware,et al.  The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family , 1995, Cell.

[57]  B. Aggarwal,et al.  Inhibition of Tumor Necrosis Factor (TNF-α)-mediated Apoptosis by Hepatitis C Virus Core Protein* , 1998, The Journal of Biological Chemistry.

[58]  C. Rice,et al.  Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini , 1994, Journal of virology.

[59]  M. Yoshida,et al.  Tax protein of HTLV-1 interacts with the Rel homology domain of NF-kappa B p65 and c-Rel proteins bound to the NF-kappa B binding site and activates transcription. , 1994, Oncogene.

[60]  B. Aggarwal,et al.  Tumor necrosis factors: developments during the last decade. , 1996, European cytokine network.

[61]  T. Maniatis,et al.  NF-κB: A lesson in family values , 1995, Cell.

[62]  D. Ballard,et al.  The Tax Oncoprotein of Human T-cell Leukemia Virus Type 1 Associates with and Persistently Activates IκB Kinases Containing IKKα and IKKβ* , 1998, The Journal of Biological Chemistry.

[63]  F. Mackay,et al.  Lymphotoxin β Receptor Triggering Induces Activation of the Nuclear Factor κB Transcription Factor in Some Cell Types* , 1996, The Journal of Biological Chemistry.

[64]  M. Sandberg,et al.  Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3 , 1997, Journal of virology.

[65]  L. Zon,et al.  Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1 , 1994, Nature.

[66]  A. Baldwin,et al.  Synergistic Activation of NF- k B by Tumor Necrosis Factor Alpha and Gamma Interferon via Enhanced I k B a Degradation and De Novo I k B b Degradation , 1997 .

[67]  S. Ghosh,et al.  A Sustained Reduction in IκB-β May Contribute to Persistent NF-κB Activation in Human Endothelial Cells* , 1996, The Journal of Biological Chemistry.

[68]  B. Dérijard,et al.  Transcription factor ATF2 regulation by the JNK signal transduction pathway , 1995, Science.

[69]  T. Maniatis,et al.  Activation of the IκBα Kinase Complex by MEKK1, a Kinase of the JNK Pathway , 1997, Cell.

[70]  V. Dixit,et al.  Recent advances in tumor necrosis factor and CD40 signaling. , 1996, Current opinion in genetics & development.

[71]  A. Sharrocks,et al.  Integration of MAP kinase signal transduction pathways at the serum response element. , 1995, Science.

[72]  M. Lai,et al.  Differential subcellular localization of hepatitis C virus core gene products. , 1995, Virology.

[73]  M. Houghton,et al.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. , 1989, Science.

[74]  D. Baltimore,et al.  NF-κB Activation: The IκB Kinase Revealed? , 1997, Cell.

[75]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[76]  B. Walker,et al.  Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV , 1993, Journal of virology.

[77]  Seamus J. Martin,et al.  Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.

[78]  E. Kieff,et al.  The Epstein–Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB , 1997 .

[79]  W. Greene,et al.  Human T-cell leukemia virus type I Tax activation of NF-kappa B/Rel involves phosphorylation and degradation of I kappa B alpha and RelA (p65)-mediated induction of the c-rel gene , 1994, Molecular and cellular biology.

[80]  D. Goeddel,et al.  The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation , 1995, Cell.

[81]  C. Ambrose,et al.  Preparation and Characterization of Soluble Recombinant Heterotrimeric Complexes of Human Lymphotoxins and (*) , 1996, The Journal of Biological Chemistry.

[82]  F. Chisari,et al.  Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. , 1995, The Journal of clinical investigation.

[83]  K. Meyer,et al.  Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. , 1995, Virus research.

[84]  M. Muramatsu,et al.  Transcriptional activator Tax of HTLV-1 binds to the NF-kappa B precursor p105. , 1992, Oncogene.

[85]  L. Zon,et al.  Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis , 1996, Nature.

[86]  W. Fiers,et al.  Two tumour necrosis factor receptors: structure and function. , 1995, Trends in cell biology.

[87]  H J Alter,et al.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. , 1990, Science.

[88]  C. Lange-Carter,et al.  A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf , 1993, Science.

[89]  David Baltimore,et al.  NF-κB: Ten Years After , 1996, Cell.

[90]  C. Rice,et al.  Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites , 1993, Journal of virology.

[91]  J. Avruch,et al.  Sounding the Alarm: Protein Kinase Cascades Activated by Stress and Inflammation* , 1996, The Journal of Biological Chemistry.

[92]  W. Greene,et al.  Human T-cell leukemia virus type I Tax associates with and is negatively regulated by the NF-kappa B2 p100 gene product: implications for viral latency , 1994, Molecular and cellular biology.

[93]  Hong-Bing Shu,et al.  TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.

[94]  M. Zafari,et al.  Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines , 1996, The Journal of experimental medicine.

[95]  David M. Rothwarf,et al.  A cytokine-responsive IκB kinase that activates the transcription factor NF-κB , 1997, Nature.

[96]  J. Bruix,et al.  PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN SPANISH PATIENTS WITH HEPATOCELLULAR CARCINOMA AND HEPATIC CIRRHOSIS , 1989, The Lancet.

[97]  M. Karin,et al.  JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain , 1994, Cell.

[98]  J. Herrero,et al.  LMP-1 Activates NF-kB by Targeting the Inhibitory Molecule IkBa , 1995 .

[99]  Y. Matsuura,et al.  Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. , 1997, Virology.

[100]  T. Tan,et al.  Interaction between c-Rel and the Mitogen-activated Protein Kinase Kinase Kinase 1 Signaling Cascade in Mediating B Enhancer Activation (*) , 1996, The Journal of Biological Chemistry.

[101]  Yan-Hwa Wu Lee,et al.  Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor , 1997, Journal of virology.

[102]  R. Gaynor,et al.  HTLV-I Tax Protein Binds to MEKK1 to Stimulate IκB Kinase Activity and NF-κB Activation , 1998, Cell.

[103]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.

[104]  L. Zon,et al.  Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun , 1994, Nature.

[105]  H. Mcdevitt,et al.  Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[106]  S. Chen,et al.  Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells , 1993, Journal of virology.

[107]  R. De Francesco,et al.  NS3 is a serine protease required for processing of hepatitis C virus polyprotein , 1993, Journal of virology.

[108]  Vijay R Baichwal,et al.  Apoptosis: Activate NF-κB or die? , 1997, Current Biology.

[109]  S. Sun,et al.  Persistent activation of NF-kappa B/Rel by human T-cell leukemia virus type 1 tax involves degradation of I kappa B beta , 1996, Journal of virology.

[110]  E. Reddy,et al.  Transducers of life and death: TNF receptor superfamily and associated proteins. , 1996, Oncogene.

[111]  M. Karin,et al.  Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. , 1993, Genes & development.

[112]  R. Bartenschlager,et al.  Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions , 1993, Journal of virology.

[113]  G. Natoli,et al.  Hepatitis B virus pX activates NF-kappa B-dependent transcription through a Raf-independent pathway , 1996, Journal of virology.

[114]  K. Meyer,et al.  Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype , 1996, Journal of virology.

[115]  A. Baldwin,et al.  Synergistic activation of NF-kappaB by tumor necrosis factor alpha and gamma interferon via enhanced I kappaB alpha degradation and de novo I kappaBbeta degradation , 1997, Molecular and cellular biology.

[116]  C. Payá,et al.  LMP-1 activates NF-kappa B by targeting the inhibitory molecule I kappa B alpha , 1995, Journal of virology.

[117]  Inder M. Verma,et al.  IκB kinase: Beginning, not the end , 1997 .